BT’s Pharma’s new white paper "Pharma Futurology" predicts that intelligent implantable microchips will be used to monitor patient compliance with medication regimes and will be able to release exact measures of medication needed to treat specific medical conditions as the body indicates they are necessary. The European pharmaceutical company also predicts that within the next decade these types of monitoring chips could be sprayed or tattooed on a patient’s skin.
Source: Health & Medicine Week via NewsRx.com
